Recent Quotes

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-04
REV		(EXPECTED)2021-08-04

Q1 2021		Est.		Actual		Surprise
EPS		2.390		2.840		0.4500
REV		2.040B		1.937B		-103.000M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
MRNA	Moderna	201.11	1.92	0.96%		80B

Moderna Frequently Asked Questions

How do I buy Moderna (MRNA) stock?

You can purchase shares of Moderna (NASDAQ: MRNA) through any online brokerage.

View our list of the best stock brokerages.

Who are Moderna's (MRNA) competitors?

Other companies in Moderna’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Amgen (NASDAQ:AMGN), BioNTech (NASDAQ:BNTX) and Natera (NASDAQ:NTRA).

What is the target price for Moderna (MRNA) stock?

The latest price target for Moderna (NASDAQ: MRNA) was reported by Chardan Capital on May 7, 2021. The analyst firm set a price target for 188.00 expecting MRNA to fall to within 12 months (a possible -5.62% downside). 34 analyst firms have reported ratings in the last year.

Current Stock Price for Moderna (MRNA)?

The stock price for Moderna (NASDAQ: MRNA) is $199.19 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Moderna (MRNA) pay a dividend?

There are no upcoming dividends for Moderna.

When is Moderna (NASDAQ:MRNA) reporting earnings?

Moderna’s Q2 earnings are confirmed for after-market on August 4, 2021.

Is Moderna (MRNA) going to split?

There is no upcoming split for Moderna.

What sector and industry does Moderna (MRNA) operate in?

Moderna is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.